A Prospective Nurse Cohort Study in Xiamen, China

NCT03799653 · tracked via the Priya Life Science China tracker

Sponsor

The First Affiliated Hospital of Xiamen University

Phase

Observational

Started

2019-03-20

Last updated

2026-09-11

Condition(s) studied

Hypertension

Investigational drug(s) / intervention(s)

No intervention

No intervention: This is a prospective observational study, and there is no intervention.

Study summary

The Nurse Cohort Study Xiamen (NCSX) is an open-ended prospective cohort study with very broad research aims. The primary objectives of the NCSX is planned to examine genetic, epigenetic, biological, psychological, social, lifestyle and other environmental factors of nurses in relation to incidence and progression of the common chronic diseases, such as hypertension, ischemic heart disease, stroke, diabetes, chronic kidney disease and some cancers, which are emerging with economic development in Xiamen, China. Specifically, we intend to test whether empirically driven hypothesis and emerging risk factors mainly developed in response to observations in economically developed Western societies apply in a population living in a rapid changing lifestyle in China now.

Eligibility

Sex

ALL

Min age

20 Years

Max age

—

Healthy volunteers

Accepted

Inclusion Criteria: * Registered nurses of public hospitals in Xiamen, China; * aged 20 years or over; * Working in the public hospitals for at least 1 year; * Signed the informed consent and agreed to participate in the study; * Assuming not moved out of Xiamen for at least 5 years; Exclusion Criteria: * who are unambulatory; * who are receiving treatment modalities, which , if omitted, may result in immediate life threatening risk such as chemotherapy or radiotherapy for cancer, or dialysis for renal failure.

Primary outcome measure(s)

Incidence rate — 2019.1.21-2024.12.31
The incidence rates of common chronic diseases, such as hypertension, The stroke, CKD and cancers

Trial sites (1)

Facility	City	Region	Status
The First Affiliated Hospital of Xiamen University	Xiamen	Fujian	Recruiting

More The First Affiliated Hospital of Xiamen University trials in China

68Ga-XACP3 PET/CT in Prostate Cancer Recruiting

T-cell Developmental Status in Patients With Malignant Hematological Tumors Recruiting

Effects of Nonsteroidal Anti-Inflammatory Drugs in Recurrence of Spondyloarthritis Patients After Remission Recruiting

Iparomlimab/Tuvorlimab (QL1706) and Modified TPF Regimen for Induction Therapy in LANPC Recruiting

Zanubrutinib in Combination With Obinutuzumab (ZO) for Newly Diagnosed Follicular Lymphoma Recruiting

Other trials for the same condition

LLM-CoManage: Large Language Model-Enabled Co-Management of Hypertension, Diabetes, and Dyslipidemia Active, not recruiting

Clinical Analysis of the Antihypertensive Effect of Laparoscopic Peripheral Nerve Blockade of the Renal Artery in Patients With Retroperitoneal Disease and Hypertension Recruiting

Goal Commitment and Proactive Health Behavior in Chronic Disease Patients Recruiting

Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation Active, not recruiting

Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension (PARADISE HTN-III) Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03799653 on ClinicalTrials.gov ↗ ← All trials in China